Related Experiment Videos
AgNOR counts in conjunctival malignant melanoma lack prognostic value
A D Paridaens1, S Seregard, D Minassian
1Department of Pathology, Institute of Ophthalmology, Utrecht, The Netherlands.
The British Journal of Ophthalmology
|October 1, 1992
Summary
The silver staining technique for argyrophilic nucleolar organiser region-associated proteins (AgNORs) cannot predict outcomes for conjunctival malignant melanomas. This method does not differentiate between aggressive and non-aggressive tumors in prognostic assessments.
Area of Science:
- Ophthalmology
- Oncology
- Cell Biology
Background:
- Conjunctival malignant melanoma (MM) is a rare but potentially aggressive ocular tumor.
- Accurate prognostic indicators are crucial for managing conjunctival MM.
- Argyrophilic nucleolar organiser region-associated proteins (AgNORs) are proteins involved in cell proliferation and have been explored as potential biomarkers.
Purpose of the Study:
- To evaluate the prognostic value of the AgNOR staining technique in conjunctival malignant melanoma.
- To determine if AgNOR counts can predict metastasis and patient survival in conjunctival MM.
Main Methods:
- A retrospective analysis of 46 invasive conjunctival malignant melanoma cases.
- Silver staining was used to quantify AgNORs in paraffin-embedded tissue sections.
- Statistical analysis included multifactor analysis of variance (ANOVA) and Cox proportional hazards regression, adjusting for tumor thickness, site, and cell type.
Main Results:
- No significant difference in mean AgNOR counts was found between cases that metastasized within 5 years and those that survived beyond 5 years (p = 0.8).
- AgNOR counts did not significantly influence patient survival according to Cox regression analysis (hazard ratio: 0.92).
- Tumor thickness, site, and cell type were considered as potential confounding factors in the analysis.
Conclusions:
- The AgNOR staining technique is not a valuable prognostic indicator for conjunctival malignant melanoma.
- While AgNORs may help differentiate benign from malignant melanocytic lesions, they do not predict the clinical outcome or survival of patients with conjunctival MM.